Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem-cell transplantation for lymphoid malignancies.
Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, et al. Darrington DL, et al. Among authors: tarantolo sr. J Clin Oncol. 1994 Dec;12(12):2527-34. doi: 10.1200/JCO.1994.12.12.2527. J Clin Oncol. 1994. PMID: 7989926
Detection of minimal residual disease in hematopoietic tissues.
Sharp JG, Bishop M, Chan WC, Greiner T, Joshi SS, Kessinger A, Reed E, Sanger W, Tarantolo S, Traystman M, et al. Sharp JG, et al. Ann N Y Acad Sci. 1995 Dec 29;770:242-61. doi: 10.1111/j.1749-6632.1995.tb31060.x. Ann N Y Acad Sci. 1995. PMID: 8597365 Review. No abstract available.
Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
Vose JM, Bierman PJ, Ruby E, Reed EC, Bishop MR, Tarantolo S, Kessinger A, Armitage JO. Vose JM, et al. Bone Marrow Transplant. 1996 Jun;17(6):951-6. Bone Marrow Transplant. 1996. PMID: 8807099 Clinical Trial.
Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies.
Pavletic ZS, Bishop MR, Tarantolo SR, Martin-Algarra S, Bierman PJ, Vose JM, Reed EC, Gross TG, Kollath J, Nasrati K, Jackson JD, Armitage JO, Kessinger A. Pavletic ZS, et al. Among authors: tarantolo sr. J Clin Oncol. 1997 Apr;15(4):1608-16. doi: 10.1200/JCO.1997.15.4.1608. J Clin Oncol. 1997. PMID: 9193360
Ex vivo treatment of bone marrow with phosphorothioate oligonucleotide OL(1)p53 for autologous transplantation in acute myelogenous leukemia and myelodysplastic syndrome.
Bishop MR, Jackson JD, Tarantolo SR, O'Kane-Murphy B, Iversen PL, Bayever E, Joshi SM, Sharp JG, Pierson JL, Warkentin PI, Armitage JO, Kessinger A. Bishop MR, et al. Among authors: tarantolo sr. J Hematother. 1997 Oct;6(5):441-6. doi: 10.1089/scd.1.1997.6.441. J Hematother. 1997. PMID: 9368180 Clinical Trial.
72 results